Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.02.2024 | Case report

Letrozole/Ribociclib

Hepatic toxicity

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Piazza F, et al. First line combination of ribociclib and letrozole in patients (pts) with metastatic breast cancer (MBC): Focus on hepatic toxicity in the context of a real-world setting the Italian, multicenter Hermione-8 study. Journal of Clinical Oncology 41 (Suppl.): abstr. e13064, No. 16, Jun 2023. Available from: URL: https://dx.doi.org/10.1200/jco.2023.41.16_suppl.e13064 [abstract] Piazza F, et al. First line combination of ribociclib and letrozole in patients (pts) with metastatic breast cancer (MBC): Focus on hepatic toxicity in the context of a real-world setting the Italian, multicenter Hermione-8 study. Journal of Clinical Oncology 41 (Suppl.): abstr. e13064, No. 16, Jun 2023. Available from: URL: https://​dx.​doi.​org/​10.​1200/​jco.​2023.​41.​16_​suppl.​e13064 [abstract]
Metadaten
Titel
Letrozole/Ribociclib
Hepatic toxicity
Publikationsdatum
01.02.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53578-0

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Aspirin

Case report

Alprostadil

Case report

Ascorbic-acid